Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Siskind

Showing results (121-130 of 292) with videos related to

Pageof 30
Sort By:
Community Mental Health Journal|October 26, 2025
Barriers and Facilitators of Smoking Cessation Among People Receiving Treatment for Mental Health Disorders: Perspectives of Healthcare ProvidersCheneal Puljević, Alice Holland, Coral Gartner, et al.
Journal of Psychiatric Research|March 24, 2020
Screening for anti-NMDAR encephalitis in psychiatryNicola Warren, Joshua Flavell, Cullen O'Gorman, et al.
Journal of Psychiatric Research|February 23, 2020
Metabolic measures 12 months after a randomised controlled trial of treatment of clozapine associated obesity and diabetes with exenatide (CODEX)Dan Siskind, A Russell, C Gamble, et al.
Journal of Psychiatric Research|May 4, 2018
Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: A systematic review and meta-analysisPadraig Oakley, Steve Kisely, Amanda Baxter, et al.
Psychopharmacology|April 29, 2018
Correction to: Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014Samantha A Hollingworth, Karl Winckel, Nargess Saiepour, et al.
The Australian and New Zealand Journal of Psychiatry|April 10, 2013
A retrospective quasi-experimental study of a community crisis house for patients with severe and persistent mental illnessDan Siskind, Meredith Harris, Steve Kisely, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 19, 2019
Serum and CSF Anti-NMDAR Antibody Testing in PsychiatryNicola Warren, Andrew Swayne, Dan Siskind, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 10, 2025
Experiences of Tobacco Smoking and Quitting Among Mental Health ConsumersHelena Roennfeldt, Marianne Wyder, Coral Gartner, et al.
BMJ Open|November 27, 2025
Sedentary time elimination with periodic activity snacks (STEPS): protocol for a codesigned feasibility trial in people with severe mental illnessMike Trott, Urska Arnautovska, Nicole Korman, et al.
Psychopharmacology|March 29, 2018
Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014Samantha A Hollingworth, Karl Winckel, Nargess Saiepour, et al.
Pageof 30

Showing results (121-130 of 292) with videos related to

Sort By:
Pageof 30
Community Mental Health Journal|October 26, 2025
Barriers and Facilitators of Smoking Cessation Among People Receiving Treatment for Mental Health Disorders: Perspectives of Healthcare ProvidersCheneal Puljević, Alice Holland, Coral Gartner, et al.
Journal of Psychiatric Research|March 24, 2020
Screening for anti-NMDAR encephalitis in psychiatryNicola Warren, Joshua Flavell, Cullen O'Gorman, et al.
Journal of Psychiatric Research|February 23, 2020
Metabolic measures 12 months after a randomised controlled trial of treatment of clozapine associated obesity and diabetes with exenatide (CODEX)Dan Siskind, A Russell, C Gamble, et al.
Journal of Psychiatric Research|May 4, 2018
Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: A systematic review and meta-analysisPadraig Oakley, Steve Kisely, Amanda Baxter, et al.
Psychopharmacology|April 29, 2018
Correction to: Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014Samantha A Hollingworth, Karl Winckel, Nargess Saiepour, et al.
The Australian and New Zealand Journal of Psychiatry|April 10, 2013
A retrospective quasi-experimental study of a community crisis house for patients with severe and persistent mental illnessDan Siskind, Meredith Harris, Steve Kisely, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 19, 2019
Serum and CSF Anti-NMDAR Antibody Testing in PsychiatryNicola Warren, Andrew Swayne, Dan Siskind, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 10, 2025
Experiences of Tobacco Smoking and Quitting Among Mental Health ConsumersHelena Roennfeldt, Marianne Wyder, Coral Gartner, et al.
BMJ Open|November 27, 2025
Sedentary time elimination with periodic activity snacks (STEPS): protocol for a codesigned feasibility trial in people with severe mental illnessMike Trott, Urska Arnautovska, Nicole Korman, et al.
Psychopharmacology|March 29, 2018
Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014Samantha A Hollingworth, Karl Winckel, Nargess Saiepour, et al.
Pageof 30